TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy October 26, 2007
TCL Archive Centers Subcommittee Kills Guidelines Proposal, Suggest Formula Ceiling On Core Grants January 6, 1978